Statistics
Total Visits
Views | |
---|---|
A phase 1, first-in-human study of AMG 900, an orally administered pan-Aurora kinase inhibitor, in adult patients with advanced solid tumors | 44 |
A phase 1, first-in-human study of AMG 900, an orally administered pan-Aurora kinase inhibitor, in adult patients with advanced solid tumors | 8 |
Total Visits per Month
September 2022 | October 2022 | November 2022 | December 2022 | January 2023 | February 2023 | March 2023 | |
---|---|---|---|---|---|---|---|
A phase 1, first-in-human study of AMG 900, an orally administered pan-Aurora kinase inhibitor, in adult patients with advanced solid tumors | 0 | 1 | 1 | 0 | 10 | 5 | 1 |
File Downloads
Views |
---|
Top Country Views
Views | |
---|---|
United States | 18 |
China | 16 |
Netherlands | 8 |
Australia | 1 |
France | 1 |
Vietnam | 1 |
Top City Views
Views | |
---|---|
Rotterdam | 8 |
Ashburn | 7 |
Zhengzhou | 6 |
Beijing | 4 |
Changchun | 3 |
Fairfield | 3 |
Des Moines | 1 |
Hanoi | 1 |
Kaleen | 1 |
Qingping | 1 |